Metropolis Healthcare Ltd press release, Q2 FY27
The company reports B2C revenue up 17% YoY to INR 289 crore and B2B revenue up 15% YoY to INR 208 crore.
By ScoutQuest · · 1 min read
- B2C revenue
- B2C revenue up 17% YoY to INR 289 crore
- B2B revenue
- B2B revenue up 15% YoY to INR 208 crore
- Revenue per patient
- Revenue per patient rose 6% YoY to INR 1,221 despite no price increase benefit
- Release
- Results press release
- Period
- Q2 FY27
_Consolidated · Q2 FY27_
📈 Revenue per patient rose 6% YoY to INR 1,221 despite no price increase benefit, and revenue per test rose 5% YoY to INR 572 on a richer test mix, per the release.
Also from Metropolis Healthcare
Metropolis Healthcare Q2 FY27: revenue up 15.8%, profit after tax up 42.7%
3 Nov 2026
Interim dividend of Rs. 1 per share declared; September quarter results approved
3 Nov 2026
Board approves results for quarter and half year ended September 30, 2026; declares interim dividend of INR 1 per share
3 Nov 2026
More numbers
- Revenue from operations, Q2 FY27496.8 (₹ crore)
- Profit before tax, Q2 FY27102.5 (₹ crore)
- Profit after tax, Q2 FY2775.5 (₹ crore)
- Reported EBITDA margin, Q2 FY2727.2%
- B2C revenue, Q2 FY27INR 289 crore
- B2B revenue, Q2 FY27INR 208 crore
- TruHealth revenue, Q2 FY27INR 86 crore
- Specialty revenue, Q2 FY27INR 198 crore
- Revenue per patient (RPP), Q2 FY27INR 1,221
- Revenue per test (RPT), Q2 FY27INR 572
- Service points5,119
- Tier III cities revenue growth, Q2 FY27around 20% YoY
Nothing here is a view, opinion or recommendation of ScoutQuest, its parent, directors or employees. ScoutQuest is a technology company: this page was assembled automatically from public sources using artificial intelligence, and may contain errors or omissions. Confirm everything against the original source before you act on it. Any use of this page is at your own risk, and neither ScoutQuest nor its parent, directors or employees accepts liability for it.